RBC LIFE SCIENCE INC

As of June 30, 2017, RBC LIFE SCIENCE INC carries a market capitalization of 619,642.80, placing it among publicly traded companies globally. Its enterprise value stands at -107,647.20, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2017, RBC LIFE SCIENCE INC has 2.21M shares outstanding.

These figures are as of June 30, 2017. The price-to-sales ratio is 0.02, and the price-to-book ratio stands at 0.09.

As of June 30, 2017, RBC LIFE SCIENCE INC maintains a current ratio of 1.75, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2017, RBC LIFE SCIENCE INC posted a negative return on equity (ROE) of -3.30, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -1.98, reflecting losses generated across the asset base. The company generates approximately 292,432.18 in revenue per employee across its workforce of 89.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.40 indicates how many times RBC LIFE SCIENCE INC sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2017, RBC LIFE SCIENCE INC recorded 94,210.00 in income tax expense. The company reported a pretax loss of -139,015.00 and -233,225.00 in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on September 4, 2026, RBC LIFE SCIENCE INC's stock has gained approximately 600.00% over the past 52 weeks. The 50-day moving average sits at 0.05, while the 200-day moving average is 0.19.

Over the twelve months ended June 30, 2017, RBC LIFE SCIENCE INC generated 26.03M in revenue and converted that into -233,225.00 in net income, yielding earnings per share of -0.11. EBITDA reached 212,681.00, while operating income came in at -139,015.00.

These figures are as of June 30, 2017. Total book value stands at 6.92M, with working capital of 3.83M providing operational flexibility.

RBC LIFE SCIENCE INC produced 298,399.00 in operating cash flow over the twelve months ended June 30, 2017. After subtracting -120,875.00 in capital expenditures, free cash flow totaled 177,524.00 - equivalent to 0.08 per share.

Over the twelve months ended June 30, 2017, RBC LIFE SCIENCE INC posted a gross margin of 53.28, reflecting its pricing power and cost economics. The operating margin of -0.53 and net profit margin of -0.90 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2017. Free cash flow yield stands at 28.65, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt.

RBC LIFE SCIENCE INC's most recent stock split took place on August 15, 2013 with a 10:1 split ratio.

As of June 30, 2017, RBC LIFE SCIENCE INC has an Altman Z-Score of 2.09, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.